Emma Anda

526 total citations
48 papers, 209 citations indexed

About

Emma Anda is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Emma Anda has authored 48 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Surgery and 6 papers in Oncology. Recurrent topics in Emma Anda's work include Thyroid Cancer Diagnosis and Treatment (26 papers), Thyroid and Parathyroid Surgery (12 papers) and Thyroid Disorders and Treatments (11 papers). Emma Anda is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (26 papers), Thyroid and Parathyroid Surgery (12 papers) and Thyroid Disorders and Treatments (11 papers). Emma Anda collaborates with scholars based in Spain, Germany and Canada. Emma Anda's co-authors include Mercedes Espada, Juan Pablo Martí­nez, Edelmiro Menéndez Torre, Guiomar Pérez de Nanclares, María José Goñi, Juan C. Galofré, Denice S. Feig, Harald Jüppner, Eva Ardanáz and Eduardo Fernández‐Rebollo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bone and Mineral Research and Thyroid.

In The Last Decade

Emma Anda

41 papers receiving 206 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Anda Spain 9 135 66 40 33 21 48 209
Fumi Kikuchi Japan 9 73 0.5× 39 0.6× 12 0.3× 38 1.2× 34 1.6× 20 185
Małgorzata Trofimiuk–Müldner Poland 11 124 0.9× 25 0.4× 26 0.7× 33 1.0× 68 3.2× 36 268
Yuka Kosuga Japan 6 250 1.9× 19 0.3× 38 0.9× 23 0.7× 20 1.0× 8 316
Amber Isaza United States 9 201 1.5× 142 2.2× 35 0.9× 21 0.6× 13 0.6× 22 239
C. Papasteriades Greece 7 65 0.5× 16 0.2× 34 0.8× 37 1.1× 6 0.3× 16 211
Tamás Solymosi Hungary 8 247 1.8× 168 2.5× 37 0.9× 17 0.5× 15 0.7× 18 305
D. K. O’Donovan Ireland 8 69 0.5× 33 0.5× 27 0.7× 30 0.9× 15 0.7× 28 171
Zafer Pekkolay Türkiye 7 41 0.3× 30 0.5× 10 0.3× 55 1.7× 64 3.0× 36 167
Evgenia Globa Ukraine 9 137 1.0× 83 1.3× 98 2.5× 66 2.0× 27 1.3× 27 222
Sarah E. Mayson United States 10 151 1.1× 77 1.2× 26 0.7× 23 0.7× 5 0.2× 14 233

Countries citing papers authored by Emma Anda

Since Specialization
Citations

This map shows the geographic impact of Emma Anda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Anda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Anda more than expected).

Fields of papers citing papers by Emma Anda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Anda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Anda. The network helps show where Emma Anda may publish in the future.

Co-authorship network of co-authors of Emma Anda

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Anda. A scholar is included among the top collaborators of Emma Anda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Anda. Emma Anda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anda, Emma, et al.. (2025). Assessment of subclinical atherosclerosis with coronary calcium score in heterozygous familial hypercholesterolemia. Acta cardiologica. Supplementum. 81(1). 94–101. 1 indexed citations
2.
Díez, Juan J., Emma Anda, Victoria Alcázar, et al.. (2025). Impaired renal function in patients with permanent hypoparathyroidism after thyroidectomy: analysis of a nationwide cohort in Spain. Endocrine. 88(3). 826–835.
3.
Díez, Juan J., Emma Anda, Victoria Alcázar, et al.. (2024). Incident comorbidities in patients with chronic hypoparathyroidism after thyroidectomy: a multicenter nationwide study. Frontiers in Endocrinology. 15. 1348971–1348971. 5 indexed citations
4.
Garcı́a, Javier, et al.. (2024). Interobserver variability in thyroid ultrasound. Endocrine. 85(2). 730–736. 10 indexed citations
5.
Gómez, Carlos García, Elena Navarro, Victoria Alcázar, et al.. (2023). Therapeutic Management and Long-Term Outcome of Hyperthyroidism in Patients with Antithyroid-Induced Agranulocytosis: A Retrospective, Multicenter Study. Journal of Clinical Medicine. 12(20). 6556–6556. 1 indexed citations
6.
Salvador, Pilar, et al.. (2022). Incidentally discovered papillary thyroid microcarcinoma in patients undergoing thyroid surgery for benign disease. Endocrine. 77(2). 325–332. 8 indexed citations
7.
Anda, Emma, et al.. (2022). Clinical characteristics and prognosis of familial nonmedullary thyroid carcinoma. Endocrinología Diabetes y Nutrición (English ed ). 69(4). 262–270. 3 indexed citations
8.
Anda, Emma, et al.. (2021). Características clínicas y pronósticas del carcinoma familiar de tiroides no medular. Endocrinología Diabetes y Nutrición. 69(4). 262–270. 3 indexed citations
9.
11.
Anda, Emma, et al.. (2018). Comparación de las características clínicas en pacientes con carcinoma folicular de tiroides y carcinoma de células de Hürthle. Endocrinología Diabetes y Nutrición. 65(3). 136–142. 6 indexed citations
12.
Torre, Edelmiro Menéndez, et al.. (2017). Aumento de la incidencia de cáncer de tiroides en Navarra. Evolución y características clínicas, 1986-2010. Endocrinología Diabetes y Nutrición. 64(6). 303–309. 9 indexed citations
13.
Goñi, María José, et al.. (2016). Incidence and Risk Factors Involved in the Development of Nephropathy in Patients with Type 1 Diabetes Mellitus: Follow Up Since Onset. Canadian Journal of Diabetes. 40(3). 258–263. 9 indexed citations
14.
Anda, Emma, et al.. (2013). Acromegalia ectópica por carcinoide bronquial. Anales del Sistema Sanitario de Navarra. 36(3). 563–567. 1 indexed citations
15.
Anda, Emma, et al.. (2012). Serie de feocromocitomas durante 15 años en Navarra. Anales del Sistema Sanitario de Navarra. 35(2). 199–205. 3 indexed citations
16.
Anda, Emma, et al.. (2010). The effects of amiodarone on the thyroid. Anales del Sistema Sanitario de Navarra. 32(3). 363–70. 3 indexed citations
17.
Forga, Lluís, et al.. (2008). Glucocorticoid hypofunction in myotonic dystrophy. Anales del Sistema Sanitario de Navarra. 30(2). 199–205. 1 indexed citations
18.
Anda, Emma, et al.. (2008). Inédita coincidencia: feocromocitoma sobre glándula suprarrenal atrófica por enfermedad de Addison. Endocrinología y Nutrición. 55(10). 510–513. 2 indexed citations
19.
Forga, Lluís, et al.. (2005). Síndromes hormonales paraneoplásicos. Anales del Sistema Sanitario de Navarra. 28(2). 213–26. 6 indexed citations
20.
Torre, Edelmiro Menéndez, et al.. (2000). Recidiva y factores pronósticos tras tratamiento con antitiroideos en la enfermedad de Graves-Basedow. Estudio multicéntrico en el norte de España. Revista Clínica Española. 200(2). 69–73. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026